Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID‐19, in Healthy Subjects

Remdesivir (RDV), a single diastereomeric monophosphoramidate prodrug that inhibits viral RNA polymerases, has potent in vitro antiviral activity against severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2). RDV received the US Food and Drug Administration (FDA)’s emergency use authorization...

Descripción completa

Detalles Bibliográficos
Autores principales: Humeniuk, Rita, Mathias, Anita, Cao, Huyen, Osinusi, Anu, Shen, Gong, Chng, Estelle, Ling, John, Vu, Amanda, German, Polina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361781/
https://www.ncbi.nlm.nih.gov/pubmed/32589775
http://dx.doi.org/10.1111/cts.12840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361781/
https://www.ncbi.nlm.nih.gov/pubmed/32589775
http://dx.doi.org/10.1111/cts.12840

Ejemplares similares